News und Analysen
EQS-Adhoc: Gerresheimer AG: Adjustment of Guidance for 2025
EQS-Adhoc: Gerresheimer AG: Adjustment of Guidance for 2025
EQS-News: Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25
EQS-News: Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25
EQS-News: Gerresheimer Successfully Completes Investment in State-of-the-Art Glass Production Facility in Lohr
EQS-News: Gerresheimer Successfully Completes Investment in State-of-the-Art Glass Production Facility in Lohr
EQS-News: Change of President and CEO at Carl Zeiss Meditec AG
EQS-News: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
EQS-News: ZEISS VISUMAX 800 with SMILE pro software receives approval in China
EQS-News: ZEISS VISUMAX 800 with SMILE pro software receives approval in China
EQS-News: Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
EQS-News: Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
EQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offer
EQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offer
EQS-News: Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
EQS-News: Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
EQS-News: Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group
EQS-News: Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group
EQS-News: Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved
EQS-News: Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved